ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,147.83
0.22%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
-0.01%
Brent Oil
82.275
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. MDxHealth SA (MDXH)

  7. MDxHealth SA (MDXH) ニュース

MDXH

MDxHealth (MDXH)

MDxHealth SA
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MDXH
日付受信時刻ニュースソース見出しコード企業名
2024/06/0606 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2024/05/1605 : 00GlobeNewswire Inc.Mdxhealth to Present at Upcoming Investor ConferencesNASDAQ:MDXHMDxHealth SA
2024/05/0120 : 45GlobeNewswire Inc.MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMedNASDAQ:MDXHMDxHealth SA
2024/03/1305 : 00GlobeNewswire Inc.Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingNASDAQ:MDXHMDxHealth SA
2024/03/0706 : 00GlobeNewswire Inc.Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:MDXHMDxHealth SA
2024/02/2207 : 00GlobeNewswire Inc.MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6NASDAQ:MDXHMDxHealth SA
2024/02/1706 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2024/01/0906 : 39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/11/1606 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/11/0906 : 23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/11/0906 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/11/0622 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/10/2406 : 09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/08/1105 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/07/0606 : 27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MDXHMDxHealth SA
2023/06/0706 : 30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/05/2705 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/05/1605 : 26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/04/2705 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/04/1505 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/03/0920 : 07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/03/0106 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDXHMDxHealth SA
2023/03/0106 : 07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MDXHMDxHealth SA
2023/02/2320 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/02/1420 : 07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDXHMDxHealth SA
2023/02/1006 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/02/0707 : 26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MDXHMDxHealth SA
2023/02/0206 : 16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MDXHMDxHealth SA
2023/01/2020 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
2023/01/1006 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MDXHMDxHealth SA
 Showing the most relevant articles for your search:NASDAQ:MDXH

最近閲覧した銘柄

NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
NYSE
AXP
American Express
CCOM
US30
US 30
COIN
SOLUSD
Solana
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
CCOM
US100
US Tech 100
NYSE
CVX
Chevron
NYSE
KO
Coca Cola
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有